Viking Therapeutics Inc.’s stock soared 90% Tuesday to a record high, after the company announced positive results from a Phase…
Browsing: medications
Kairos Pharma plans to sell about 1.55 million shares in its initial public offering at $4 per share. The Los…
AbbVie Inc.’s stock fell 0.5% early Monday, after the biotech lowered its first-quarter guidance to reflect the dilutive impact of…
Novartis AG on Monday announced it has agreed to buy German biopharmaceutical company MorphoSys AG for 2.7 billion euros ($2.9…
The controlling shareholder of weight-loss drug maker Novo Nordisk on Monday said it’s buying a provider of drug manufacturing for…
Cancer drug company CG Oncology Inc. priced its initial public offering above its estimated range and added three million shares…
Merck & Co. announced Monday an agreement to buy cancer-treatment developer Harpoon Therapeutics Inc. in a deal valued at $680…
Eli Lilly & Co. on Thursday announced the launch of new digital health services that could help smooth patient access…
Losing weight is one of the top New Year’s resolutions that people make year after year, and with good reason.…
Bladder-cancer treatment developer CG Oncology filed for an initial public offering with the Securities and Exchange Commission. The Irvine, Calif.-based…